![](/img/cover-not-exists.png)
PD-016Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+ esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ)
Ryan, D.P., Murphy, J., Mahalingam, D., Strickler, J., Stein, S., Sirard, C., Landau, S., Bendell, J.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw200.16
Date:
June, 2016
File:
PDF, 66 KB
2016